Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,382	10,654	8,050	-	-	-
Market Cap Growth	19.12%	32.35%	-	-	-	-
Enterprise Value	11,202	10,534	7,954	-	-	-
Last Close Price	162.60	149.08	110.34	-	-	-
PE Ratio	26.13	29.88	27.53	-	-	-
Forward PE	24.29	25.61	25.41	-	-	-
PS Ratio	7.90	8.08	7.31	-	-	-
PB Ratio	6.77	7.15	5.73	-	-	-
P/TBV Ratio	6.83	7.20	5.79	-	-	-
P/FCF Ratio	43.54	51.60	32.10	-	-	-
P/OCF Ratio	37.30	40.46	27.20	-	-	-
PEG Ratio	1.74	1.60	1.01	-	-	-
EV/Sales Ratio	7.77	7.99	7.23	-	-	-
EV/EBITDA Ratio	21.93	24.82	23.28	-	-	-
EV/EBIT Ratio	23.81	27.16	25.19	-	-	-
EV/FCF Ratio	42.85	51.02	31.72	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	0.01	0.00	0.01	0.01	0.01	0.34
Debt / FCF Ratio	0.02	0.01	0.01	0.02	0.02	0.86
Asset Turnover	0.74	0.77	0.72	0.65	0.50	0.58
Inventory Turnover	2.21	1.98	2.18	2.44	1.97	2.99
Quick Ratio	3.13	3.65	3.58	4.16	3.90	2.90
Current Ratio	4.19	5.10	5.04	5.42	5.06	3.54
Return on Equity (ROE)	27.71%	24.63%	22.32%	14.00%	14.16%	18.40%
Return on Assets (ROA)	14.41%	14.15%	12.89%	10.67%	7.93%	10.79%
Return on Capital (ROIC)	17.82%	16.72%	15.04%	12.36%	9.25%	12.59%
Return on Capital Employed (ROCE)	25.40%	24.70%	21.40%	18.90%	14.40%	19.10%
Earnings Yield	3.83%	3.35%	3.63%	-	-	-
FCF Yield	2.30%	1.94%	3.12%	-	-	-
Dividend Yield	1.88%	2.05%	2.27%	-	-	-
Payout Ratio	49.17%	60.87%	23.94%	86.85%	66.40%	43.83%
Buyback Yield / Dilution	-	-	-	-600.00%	-	-
Total Shareholder Return	1.90%	2.05%	2.27%	-600.00%	-	-

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.